Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/119771
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2024-03-12T11:26:09Z-
dc.date.available2024-03-12T11:26:09Z-
dc.date.issued2024-
dc.identifier.citationScicluna, R. (2024). Gene targeting in lung cancer (Master's dissertation).en_GB
dc.identifier.urihttps://www.um.edu.mt/library/oar/handle/123456789/119771-
dc.descriptionM.Sc.(Melit.)en_GB
dc.description.abstractLung cancer is one of the leading causes of cancer death in the world, whilst being the most common malignancy in men and third most common cancer in women. One of the main deregulated pathways within lung cancer is the mTOR pathway. The downstream effects of this deregulation causes high levels of free eIF4E within the cell, promoting oncogenic networks such as increased proliferation, metastasis and cell survival. This project aimed to investigate the effects of eIF4E inhibition in NSCLC, both by treating commercial cell lines with small-molecule eIF4E inhibitors and also investigating the effects of knockdown by siRNA of eIF4E. Using three different cell lines, each with unique characteristics depending on their subtype of NSCLC were used throughout the project. The two small-molecule inhibitors were Briciclib and 4E1RCat, where Briciclib showed a large and significant decrease in cell viability at low concentrations throughout the cell lines, as opposed to 4E1RCat which did not show significant decreases in cell viability when treating with low dosages. ELISA assays were then performed on cells treated with Briciclib by investigating the effects of the drug on Cyclin D1, which is found downstream of eIF4E. Results showed a decrease in Cyclin D1 expression. Finally, transfections were used to knockdown eIF4E through an siRNA. Conditions were optimised prior to knockdown of eIF4E using siGLO and flowcytometry. Knockdown was then performed and cell viability assays were used to observe any initial effects on the cell lines but it was seen that there was little to no decrease in cell viability upon knockdown. qPCR was performed and showed large decreases in eIF4E expression. These results were seen to be promising and worth investigating further in the future, such as investigation of the effects of Briciclib in primary cells to investigate the cytotoxicity of the drug further, and also investigating the effects of knockdown of eIF4E along with inhibition through small-molecules to increase the efficacy of the two. Finally, these results confirm that there is a decrease in cap-dependent translation of oncogenes within the cancer cell line, which in turn decreases cell viability and increases cell death.en_GB
dc.language.isoenen_GB
dc.rightsinfo:eu-repo/semantics/restrictedAccessen_GB
dc.subjectLungs -- Canceren_GB
dc.subjectGene targetingen_GB
dc.subjectCytologyen_GB
dc.subjectBiological assayen_GB
dc.titleGene targeting in lung canceren_GB
dc.typemasterThesisen_GB
dc.rights.holderThe copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder.en_GB
dc.publisher.institutionUniversity of Maltaen_GB
dc.publisher.departmentFaculty of Medicine and Surgeryen_GB
dc.description.reviewedN/Aen_GB
dc.contributor.creatorScicluna, Rachel (2024)-
Appears in Collections:Dissertations - FacM&S - 2023
Dissertations - FacM&S - 2024

Files in This Item:
File Description SizeFormat 
2419MDSMDS510000012157_1.PDF
  Restricted Access
5.11 MBAdobe PDFView/Open Request a copy


Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.